Proposed Data Collections Submitted for Public Comment and Recommendations, 3430-3431 [2013-00755]
Download as PDF
3430
Federal Register / Vol. 78, No. 11 / Wednesday, January 16, 2013 / Notices
time per response for screening and
recruitment is 12 minutes, for a total
annualized burden of 204 hours.
This request is submitted to extend
OMB clearance for one year. There is no
cost to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Parents of adolescents (aged 15–17)
living with SCD.
Young adults (aged 18–25) living
with SCD
Adults (aged 26–35) living with SCD
Older adults (aged 36+) living with
SCD
Parents of adolescents (aged 15–17)
living with SCD.
Young adults (aged 18–25) living
with SCD
Adults (aged 26–35) living with SCD
Older adults (aged 36+) living with
SCD.
Participant Screener and Recruitment Script.
120
1
12/60
24
Focus Group Moderator’s Guide .....
90
1
2
180
Total ...........................................
..........................................................
........................
........................
........................
204
Dated: January 8, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013–00806 Filed 1–15–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Proposed Project
Colorectal Cancer Screening Program
(OMB No. 0920–0745, exp. 6/30/2013)—
Extension—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
Background and Brief Description
Of cancers affecting both men and
women, Colorectal Cancer (CRC) is the
second leading cause of cancer-related
deaths in the United States. Based on
scientific evidence which indicates that
regular screening is effective in reducing
CRC incidence and mortality, regular
CRC screening is now recommended for
adults starting at age 50 and continuing
until age 75 years. Screening tests that
are recommended by the United States
Preventive Services Task Force, and that
may be used alone or in combination,
include fecal occult blood testing
(FOBT), fecal immunochemical testing
(FIT), flexible sigmoidoscopy, and
colonoscopy.
In 2005, CDC established a three-year
demonstration program, subsequently
extended to four years, to screen low-
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with
[60Day–13–0745]
VerDate Mar<15>2010
17:01 Jan 15, 2013
Jkt 229001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
income individuals 50 years of age and
older who have no health insurance or
inadequate health insurance for CRC.
The five demonstration sites reported
information to CDC including deidentified, patient-level demographic,
screening, diagnostic, treatment,
outcome and cost reimbursement data
(Colorectal Cancer Screening
Demonstration Program, OMB No.
0920–0745, exp. 7/31/2010). The
information was used to assess the
feasibility and cost effectiveness of a
publicly funded screening program,
describe key outcomes, and guide
program expansion.
In 2009, CDC received additional
funding from Congress and established
the expanded Colorectal Cancer Control
Program (CRCCP) to increase screening
rates in the general population through
evidence-based screening provision and
screening promotion activities. All
funded sites provide CRC screening and
follow-up services to low-income men
and women who are underinsured or
uninsured for CRC screening. Funded
sites also plan and implement program
activities that promote CRC screening in
the general population through policy,
systems, community and individual
level interventions. With expanded
CRCCP support, the number of sites
funded to provide CRC screening
services increased from five to 26 and
the original information collection was
revised. Changes incorporated through
the revision process included an
increase in the number of respondents;
simplification of the clinical data
collection based on experience with the
five demonstration program sites;
E:\FR\FM\16JAN1.SGM
16JAN1
3431
Federal Register / Vol. 78, No. 11 / Wednesday, January 16, 2013 / Notices
discontinuation of the cost
reimbursement data collection; addition
of an activity-based economic data
collection; and deletion of the term
‘‘Demonstration’’ from the title.
Information currently reported to CDC
includes program-level activity cost
data, and de-identified patient-level
demographic, screening, diagnostic,
treatment and outcome data (Colorectal
Cancer Screening Program, OMB No.
0920–0745, exp. 6/30/2013).
CDC plans to request a three-year
extension of the current approval. No
changes are proposed to the content of
the information collection, reporting
procedures for awardees, or the
estimated burden per respondent.
However, the number of funded CRC
screening sites will increase from 26 to
29.
Program awardees will continue to
implement evidence-based
approach has been employed for a
number of CDC-funded cancer programs
(see Economic Analysis of the National
Breast and Cervical Cancer Early
Detection Program, OMB No. 0920–
0776, exp. 3/31/2011, and Economic
Analysis of the National Program of
Cancer Registries, OMB No. 0920–0812,
exp. 6/30/2012).
CDC will use the information
collected from Colorectal Cancer
Screening Program awardees to monitor
and evaluate the CRC screening program
and funded sites; improve the quality of
screening and diagnostic services for
underserved individuals; develop
outreach strategies to increase
screening; and report program results to
Congress and other legislative
authorities. Participation is required for
all CRCCP awardees. There are no costs
to respondents other than their time.
interventions to increase populationlevel screening rates and to address
disparities in access to CRC screening
services.
Through this program, funded
awardees will provide CRC screening
services to low-income individuals 50
years of age and older who have no
health insurance or inadequate health
insurance for CRC. On average, each
program awardee is expected to provide
services to 375 individuals per year. Deidentified clinical data elements will be
reported to CDC electronically. In
addition, each awardee will collect and
report program-level activity-based cost
data to CDC through an electronic Cost
Assessment Tool (CAT). The activitybased cost information allows CDC to
monitor individual awardees and
compare activity-based costs across
multiple sites and programs. A similar
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form type
Colorectal Cancer Control Program
Awardees.
Clinical Data Elements .....................
29
375
15/60
2,719
Cost Assessment Tool .....................
29
1
22
638
...........................................................
........................
........................
........................
3,357
Total ...........................................
Dated: January 8, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013–00755 Filed 1–15–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
mstockstill on DSK4VPTVN1PROD with
Proposed Information Collection
Activity; Comment Request
Title: School Readiness Goals and
Head Start Program Functioning.
OMB No.: New Collection.
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS) is proposing a data
collection as part of the ‘‘School
Readiness Goals and Head Start Program
VerDate Mar<15>2010
17:01 Jan 15, 2013
Jkt 229001
Functioning’’ research project. The
purpose of this study is to improve
understanding of how local Head Start
and Early Head Start programs define,
measure, and communicate school
readiness goals, and how they use these
goals in program planning to improve
program functioning. ACF is proposing
to use a semi-structured telephone
interview protocol to collect
information from program directors and
other key staff from approximately 60
local grantees and site visit protocols to
collect further qualitative information
through interviews and/or focus groups
with program staff, oversight boards,
key stakeholders, and parents in a
subset of 12 of these grantees. ACF has
contracted with the Urban Institute to
collect and analyze the data gathered in
the telephone interviews and site visits.
Topics to be covered in the telephone
interview and site visit protocols
include: A description of school
readiness goals set by local grantee; the
process used to set school readiness
goals; contextual factors informing
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
choices made about school readiness
goals (e.g., needs of local children and
families, program and staff
characteristics, and community
characteristics); how programs use and
analyze data about school readiness
goals; how programs report progress on
goals; and how school readiness goals
and data form program planning and
improvement efforts.
Respondents: Head Start and Early
Head Start program directors and
managers closely involved with school
readiness goal setting (e.g. education
services coordinators); others in
leadership positions (e.g. agency
directors, center directors, home-based
services coordinators or assistant
program directors); front-line staff (e.g.
Head Start teachers, Early Head Start
teachers, home visitors, family service
workers, and program specialists);
members of Head Start governing bodies
and local policy councils; liaisons from
local education agencies; and parents
with children in Head Start and Early
Head Start programs.
E:\FR\FM\16JAN1.SGM
16JAN1
Agencies
[Federal Register Volume 78, Number 11 (Wednesday, January 16, 2013)]
[Notices]
[Pages 3430-3431]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00755]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0745]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Colorectal Cancer Screening Program (OMB No. 0920-0745, exp. 6/30/
2013)--Extension--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Of cancers affecting both men and women, Colorectal Cancer (CRC) is
the second leading cause of cancer-related deaths in the United States.
Based on scientific evidence which indicates that regular screening is
effective in reducing CRC incidence and mortality, regular CRC
screening is now recommended for adults starting at age 50 and
continuing until age 75 years. Screening tests that are recommended by
the United States Preventive Services Task Force, and that may be used
alone or in combination, include fecal occult blood testing (FOBT),
fecal immunochemical testing (FIT), flexible sigmoidoscopy, and
colonoscopy.
In 2005, CDC established a three-year demonstration program,
subsequently extended to four years, to screen low-income individuals
50 years of age and older who have no health insurance or inadequate
health insurance for CRC. The five demonstration sites reported
information to CDC including de-identified, patient-level demographic,
screening, diagnostic, treatment, outcome and cost reimbursement data
(Colorectal Cancer Screening Demonstration Program, OMB No. 0920-0745,
exp. 7/31/2010). The information was used to assess the feasibility and
cost effectiveness of a publicly funded screening program, describe key
outcomes, and guide program expansion.
In 2009, CDC received additional funding from Congress and
established the expanded Colorectal Cancer Control Program (CRCCP) to
increase screening rates in the general population through evidence-
based screening provision and screening promotion activities. All
funded sites provide CRC screening and follow-up services to low-income
men and women who are underinsured or uninsured for CRC screening.
Funded sites also plan and implement program activities that promote
CRC screening in the general population through policy, systems,
community and individual level interventions. With expanded CRCCP
support, the number of sites funded to provide CRC screening services
increased from five to 26 and the original information collection was
revised. Changes incorporated through the revision process included an
increase in the number of respondents; simplification of the clinical
data collection based on experience with the five demonstration program
sites;
[[Page 3431]]
discontinuation of the cost reimbursement data collection; addition of
an activity-based economic data collection; and deletion of the term
``Demonstration'' from the title. Information currently reported to CDC
includes program-level activity cost data, and de-identified patient-
level demographic, screening, diagnostic, treatment and outcome data
(Colorectal Cancer Screening Program, OMB No. 0920-0745, exp. 6/30/
2013).
CDC plans to request a three-year extension of the current
approval. No changes are proposed to the content of the information
collection, reporting procedures for awardees, or the estimated burden
per respondent. However, the number of funded CRC screening sites will
increase from 26 to 29.
Program awardees will continue to implement evidence-based
interventions to increase population-level screening rates and to
address disparities in access to CRC screening services.
Through this program, funded awardees will provide CRC screening
services to low-income individuals 50 years of age and older who have
no health insurance or inadequate health insurance for CRC. On average,
each program awardee is expected to provide services to 375 individuals
per year. De-identified clinical data elements will be reported to CDC
electronically. In addition, each awardee will collect and report
program-level activity-based cost data to CDC through an electronic
Cost Assessment Tool (CAT). The activity-based cost information allows
CDC to monitor individual awardees and compare activity-based costs
across multiple sites and programs. A similar approach has been
employed for a number of CDC-funded cancer programs (see Economic
Analysis of the National Breast and Cervical Cancer Early Detection
Program, OMB No. 0920-0776, exp. 3/31/2011, and Economic Analysis of
the National Program of Cancer Registries, OMB No. 0920-0812, exp. 6/
30/2012).
CDC will use the information collected from Colorectal Cancer
Screening Program awardees to monitor and evaluate the CRC screening
program and funded sites; improve the quality of screening and
diagnostic services for underserved individuals; develop outreach
strategies to increase screening; and report program results to
Congress and other legislative authorities. Participation is required
for all CRCCP awardees. There are no costs to respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form type respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Colorectal Cancer Control Clinical Data 29 375 15/60 2,719
Program Awardees. Elements.
Cost Assessment 29 1 22 638
Tool.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,357
----------------------------------------------------------------------------------------------------------------
Dated: January 8, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-00755 Filed 1-15-13; 8:45 am]
BILLING CODE 4163-18-P